Dermata Therapeutics, Inc. · NASDAQ:DRMA
Dermata Therapeutics, Inc. shareholders
As of Sep 30, 2026, 15 institutions reported holding Dermata Therapeutics, Inc., 3.5% of its shares. Largest: Citadel, Geode Capital and Welch & Forbes LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Dermata Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Citadel | 32,796 | 0.67% | new | Nov 16, 2026 |
| Geode Capital | 20,101 | 0.41% | −102 | Nov 6, 2026 |
| Welch & Forbes LLC | 20,000 | 0.41% | no change | Nov 4, 2026 |
| Hrt Financial LP | 19,403 | 0.39% | new | Nov 13, 2026 |
| State Street | 18,747 | 0.38% | no change | Nov 12, 2026 |
| UBS | 17,115 | 0.35% | +319 | Nov 10, 2026 |
| Jane Street | 16,589 | 0.34% | new | Nov 12, 2026 |
| XTX Topco Ltd | 12,877 | 0.26% | −1,910 | Nov 16, 2026 |
| Citigroup Inc | 6,625 | 0.13% | new | Nov 4, 2026 |
| Vanguard | 5,438 | 0.11% | new | Nov 13, 2026 |